Live Conference Coverage AACR 2020 in Real Time: Monday June 22, 2020 8AM-Noon Sessions

« A Group of Leading Scientists is calling on PNAS to retract a Nobel Laureate’s paper

Live Conference Coverage AACR 2020 in Real Time: Monday June 22, 2020 Mid Day Sessions »

Live Conference Coverage AACR 2020 in Real Time: Monday June 22, 2020 8AM-Noon Sessions

June 22, 2020 by sjwilliamspa

Live Conference Coverage AACR 2020 in Real Time: Monday June 22, 2020 8AM-Noon Sessions

Reporter: Stephen J. Williams, PhD

Follow Live in Real Time using

#AACR20

@pharma_BI

@AACR

Register for FREE at https://www.aacr.org/

AACR VIRTUAL ANNUAL MEETING II

June 22-24: Free Registration for AACR Members, the Cancer Community, and the Public
This virtual meeting will feature more than 120 sessions and 4,000 e-posters, including sessions on cancer health disparities and the impact of COVID-19 on clinical trials

This Virtual Meeting is Part II of the AACR Annual Meeting. Part I was held online in April and was centered only on clinical findings. This Part II of the virtual meeting will contain all the Sessions and Abstracts pertaining to basic and translational cancer research as well as clinical trial findings.

REGISTER NOW

Monday, June 22

8:30 AM – 10:10 AM EDT

Virtual Special Session

Opening Ceremony

The Opening Ceremony will include the following presentations:
Welcome from AACR CEO Margaret Foti, PhD, MD (hc)

CHIEF EXECUTIVE OFFICER

MARGARET FOTI, PHD, MD (HC)

American Association for Cancer Research
Philadelphia, Pennsylvania

Dr. Foti mentions that AACR is making progress in including more ethnic and gender equality in cancer research and she feels that the disparities seen in health care, and in cancer care, is related to the disparities seen in the cancer research profession
AACR is very focused now on blood cancers and creating innovation summits on this matter
In 2019 awarded over 60 grants but feel they will be able to fund more research in 2020
Government funding is insufficient at current levels

Remarks from AACR Immediate Past President Elaine R. Mardis, PhD, FAACR

involved in planning and success of the first virtual meeting (it was really well done)
# of registrants was at unprecedented numbers
the scope for this meeting will be wider than the first meeting
they have included special sessions including COVID19 and health disparities
70 educational and methodology workshops on over 70 channels

AACR Award for Lifetime Achievement in Cancer Research

Dr. Philip Sharp is awardee of Lifetime Achievement Award
Dr. Sharp is known for his work in RNA splicing and development of multiple cancer models including a mouse CRSPR model
worked under Jim Watson at Cold Spring Harbor
Presentation of New Fellows of the AACR Academy
Dr. Radcliffe for hypoxic factors
CART therapies
Dr. Semenza for HIF1 discovery
Dr Swanton for stratification of patients and tumor heterogeneity
these are just some of the new fellows

AACR-Biedler Prizes for Cancer Journalism

Writer of Article War of Nerves awarded; reported on nerve intervation of tumors
writer Budman on reporting and curation of hedgehog inhibitors in cancers
patient advocacy book was awarded for journalism
cancer survivor Kasie Newsome produced multiple segments on personalized cancer therapy from a cancer survivor perspective

Remarks from Speaker of the United States House of Representatives Nancy Pelosi

helped secure a doubling of funding for NCI and NIH in the 90s
securing COVID funding to offset some of the productivity issues related to the shutdown due to COVID
advocating for more work to alleviate health disparities

Remarks from United States Senator Roy Blunt

tireless champion in the Senate for cancer research funding; he was a cancer survivor himself
we need to keep focus on advances in science

Margaret Foti

DETAILS

Monday, June 22

10:10 AM – 12:30 PM EDT

Virtual Plenary Session

Bioinformatics and Systems Biology, Epidemiology, Immunology, Molecular and Cellular Biology/Genetics

Opening Plenary Session: Turning Science into Lifesaving Care

Alexander Marson, Antoni Ribas, Ashani T Weeraratna, Olivier Elemento, Howard Y Chang, Daniel D. De Carvalho

DETAILS

Monday, June 22

12:45 PM – 1:30 PM EDT

Awards and Lectures

How should we think about exceptional and super responders to cancer therapy? What biologic insights might ensue from considering these cases? What are ways in which considering super responders may lead to misleading conclusions? What are the pros and cons of the quest to locate exceptional and super responders?

Alice P Chen, Vinay K Prasad, Celeste Leigh Pearce

DETAILS

Monday, June 22

1:30 PM – 3:30 PM EDT

Virtual Educational Session

Tumor Biology, Immunology

Experimental and Molecular Therapeutics, Immunology

Other Articles on this Open Access Online Journal on Cancer Conferences and Conference Coverage in Real Time Include